Estimates of the prevalence of NAFLD in adolescents in the US and Australia defined by a variety of methods including autopsy, ultrasound, and ALT, range from 10% to 17% [3,29,36]. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.